School of Medicine


Showing 281-290 of 466 Results

  • Claudia Mueller

    Claudia Mueller

    Associate Professor of Surgery (Pediatric Surgery)
    On Partial Leave from 2026-10-01 To 2027-01-01

    Current Research and Scholarly InterestsInvestigations of how children's beliefs of health affect their responses to illness.

  • Adel Mutahar

    Adel Mutahar

    Postdoctoral Scholar, General and Vascular Surgery

    BioDr. Adel Z. I. Mutahar is a postdoctoral researcher in the Department of Surgery at Stanford University, working under the mentorship of Dr. Frederick M. Dirbas. His research focuses on translational breast cancer biology and emerging radiotherapy technologies, with an emphasis on tumor–microenvironment interactions, immuno-oncology, and preclinical therapeutic development. His academic journey spans three countries—beginning in Yemen, advancing through India, and now progressing at Stanford—reflecting his commitment to impactful cancer research and global scientific advancement.
    Dr. Mutahar began his career in Yemen, earning his Bachelor’s degree in Medical Laboratory Sciences before joining Abs Community College as a faculty member. From 2007–2013, he held several academic leadership roles, including Academic Director, Head of Evaluation, and Assistant Dean of Students, where he modernized curriculum, expanded hands-on diagnostic training, and strengthened laboratory education infrastructure in resource-limited settings. His work contributed to building a more skilled medical diagnostics workforce and improving pathways for laboratory science education.
    Awarded a prestigious national merit scholarship, Dr. Mutahar continued his graduate and doctoral training in India, completing his M.S. and Ph.D. in Biotechnology with a focus on triple-negative breast cancer. During his doctoral work, he developed 3D tumor spheroid models and combinatorial therapeutic strategies, demonstrating synergy between anti-angiogenic agents and chemotherapy in TNBC. He further advanced this research by creating an orthotopic murine model to investigate metastatic progression and demonstrated that knockdown of the MTA1 gene in mesenchymal stem cells (MSCs) significantly suppressed TNBC invasion, angiogenesis, and metastatic spread, introducing a promising stromal-targeted therapeutic concept for aggressive breast cancer. This work earned recognition through travel grants, conference presentations, and a Best Poster Award. His scientific adaptability was further demonstrated during the COVID-19 pandemic, when he uncovered a novel interaction between SARS-CoV-2 Spike RBD and VEGF signaling.
    At Stanford, his work emphases on FLASH radiotherapy, an ultrahigh-dose-rate modality with the potential to widen the therapeutic window by minimizing normal-tissue toxicity while maintaining tumor control. Working within Dr. Dirbas’s translational breast oncology program, Dr. Mutahar employs patient-derived xenografts, orthotopic murine models, spatial transcriptomics, single-cell RNA sequencing, and immune profiling to dissect the biological mechanisms governing treatment response. His research integrates multi-omics analysis to map early and late radiotherapy injury pathways—including senescence, apoptosis and fibrosis. His goal is to develop mechanism-driven radio-immunotherapy strategies and durable FLASH-RT combination regimens that can be translated into clinical trials for breast cancer, improving therapeutic durability, minimizing toxicity, and ultimately enhancing patient outcomes.
    Dr. Mutahar’s long-term vision is to establish an independent laboratory at the intersection of radiobiology, immuno-oncology, and translational therapeutics. Guided by Dr. Dirbas’s mentorship and shaped by multidisciplinary experience across three continents, he aims to develop biologically informed treatment strategies that eradicate tumors while preserving normal tissue and immune integrity—ultimately improving quality of life and survival for women with aggressive breast cancers.

  • Aussama Nassar, MD, MSc,FACS, FRCSC

    Aussama Nassar, MD, MSc,FACS, FRCSC

    Clinical Professor, Surgery - General Surgery

    BioDr. Nassar is a Clinical Professor of Surgery at Stanford University School of Medicine and a nationally recognized leader in surgical education, quality improvement, and innovation in acute care surgery. Board-certified in General Surgery and Surgical Critical Care in both the United States and Canada, he trained at McMaster University, where he also earned a Master of Science in Health Science Education. He is a graduate of the Harvard Surgical Leadership Program and the Stanford Biodesign Faculty Fellowship.

    As the inaugural Medical Director of the Emergency General Surgery Service at Stanford Health Care, Dr. Nassar built the service’s quality program from the ground up, establishing its patient registry, quality dashboard, and standardized clinical pathways. He also serves as a Unit-Based Medical Director, and his labeled surgical caps initiative has been adopted by institutions nationally to improve teamwork and safety in the operating room. His clinical practice spans the full scope of acute care surgery, with particular expertise in robotic surgery, hernia repair and complex abdominal wall reconstruction.

    A dedicated clinician-educator, Dr. Nassar has directed the Surgical Critical Care Fellowship, doubling its size. He founded the Stanford Surgery Resident Communication Coaching Program. He serves as an Examination Consultant to the American Board of Surgery for the Surgical Critical Care certifying examination, and is a course director for ATLS and ASSET.

    Dr. Nassar is the co-founder of the TRACS Lab (Translational Research in Acute Care Surgery), where his research focuses on developing innovative AI-based solutions, including risk prediction and clinical decision support, and translating them into the practice of acute care surgery. He holds a U.S. patent for an abdominal fascial closure device. He has authored more than 60 peer-reviewed publications, contributed chapters to leading surgical textbooks and national consensus guidelines through the American Association for the Surgery of Trauma, and serves as Editor-in-Chief of the Surgical Critical Care section of StatPearls.

    In addition to his educational initiatives, Dr. Nassar is actively engaged in developing innovative assessment tools for surgical trainees and addressing burnout among physicians and healthcare professionals. With a strong national and international presence, Dr. Nassar continues to shape the future of surgical education and healthcare delivery through his leadership, research, and advocacy.

  • Rahim Nazerali, MD, MHS, FACS

    Rahim Nazerali, MD, MHS, FACS

    Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Nazerali specializes in complex reconstruction, microsurgery, and aesthetic and cosmetic surgery. He excels at breast reconstruction using free autologous tissue and performs advanced techniques such as the minimally invasive superficial inferior epigastric artery (SIEA) flap, as well as the deep inferior epigastric artery perforator (DIEP) flap procedure. In addition to autologous reconstruction, Dr. Nazerali utilizes the latest techniques in implant-based breast reconstruction. His techniques and results have made him a leading instructor and lecturer at national and international institutions, societies and conferences.

    In addition to breast reconstruction, Dr. Nazerali performs both aesthetic as well as whole body reconstructive procedures. He has a busy aesthetic practice focusing on breast augmentation, face and body rejuvenation as well as body contouring. In his reconstructive practice, he specializes in abdominal wall reconstruction as well as post-trauma tissue transfers. For every patient in his care, his goal is to optimize restoration of both form and function.

    To help advance the field of plastic and reconstructive surgery, Dr. Nazerali conducts research into outcomes of breast reconstruction, augmentation, and reduction. Dr. Nazerali has published widely: well over 100 journal articles and conference proceedings. Topics include breast reconstruction after radiation; advances in surgical technique; and, the use of virtual, augmented, and mixed reality systems in plastic surgery practice and education. His work has appeared in Annals of Plastic Surgery, Plastic and Reconstructive Surgery, Surgery, the European Journal of Plastic Surgery, the Aesthetic Surgery Journal, and elsewhere.

    Dr. Nazerali focuses not only on improving his patient’s lives but also our ability to deliver care as an institution. He is on the Medical Executive Council at Stanford Healthcare, serves as a committee member in the American Society of Plastic Surgeons as well as the California Society of Plastic Surgeons. In his spare time, he volunteers his time to provide reconstructive surgical services to adults and children in need worldwide.

  • Kevin Nee, MD, PhD

    Kevin Nee, MD, PhD

    Resident in Surgery

    BioDr. Nee is a general surgery resident at Stanford, Department of Surgery. He completed his MD/PhD training at UC Irvine: School of Medicine in the Medical Scientist Training Program. His dissertation research focused on defining pericytes, fibroblasts, and adipocytes in breast cancer using single-cell RNA sequencing.